AstraZeneca PLC (AZN)
NASDAQ: AZN · Real-Time Price · USD
90.18
+0.15 (0.17%)
At close: Dec 5, 2025, 4:00 PM EST
90.40
+0.22 (0.24%)
After-hours: Dec 5, 2025, 7:00 PM EST
AstraZeneca Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for AstraZeneca.
Price Target: $0.00 (0.00%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AstraZeneca stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold → Strong Buy Initiates n/a | Hold → Strong Buy | Initiates | n/a | n/a | Oct 27, 2025 |
| UBS | UBS | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Feb 13, 2025 |
| UBS | UBS | Strong Sell → Hold Upgrades n/a | Strong Sell → Hold | Upgrades | n/a | n/a | Nov 20, 2024 |
| Erste Group | Erste Group | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Sep 11, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $90 → $95 | Strong Buy | Maintains | $90 → $95 | +5.34% | Aug 12, 2024 |
Financial Forecast
Revenue This Year
60.20B
from 54.07B
Increased by 11.33%
Revenue Next Year
63.86B
from 60.20B
Increased by 6.08%
EPS This Year
4.68
from 4.50
Increased by 4.10%
EPS Next Year
5.31
from 4.68
Increased by 13.42%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 62.4B | 68.6B | ||||
| Avg | 60.2B | 63.9B | ||||
| Low | 53.9B | 56.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 15.4% | 13.9% | ||||
| Avg | 11.3% | 6.1% | ||||
| Low | -0.3% | -6.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 4.94 | 5.98 | ||||
| Avg | 4.68 | 5.31 | ||||
| Low | 3.94 | 4.64 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 9.8% | 27.6% | ||||
| Avg | 4.1% | 13.4% | ||||
| Low | -12.4% | -1.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.